J Korean Cancer Assoc.  2001 Feb;33(1):84-91.

Clinical Significance of p53, c-erbB-2, Chromogranin A and PCNA in the Ampullary Carcinoma

  • 1Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.


PURPOSE: To determine the clinical significance of p53, c-erbB-2, chromogranin A (CgA), proliferating cell nuclear antigen (PCNA) expression in ampullary carcinoma, a retrospective study was performed.
The cases of 96 patients who underwent curative resection for ampullary carcinoma during the ten-year period (1986-95) were reviewed. And, using paraffin-embedded tumor tissues, immunohistochemical (IHC) staining for p53, c-erbB-2, CgA, and PCNA was performed.
The overall five-year survival rate (5-YSR) for these 96 patients was 58%. With regard to TNM stage, the 5-YSR was 71% for stage I (n=36), 62% for stage II (n=29), and 39% for stage III (n=31), respectively. IHC expression rate was 17.6% for c-erbB-2, 19.2% for CgA, and 42.9% for p53. The relative proportion of labelling index of PCNA (<25%, 25-50%, >50%) was 30.8%, 25.3%, and 44.0%, respectively. The PCNA labelling index showedsignificant correlation with tumor size (p=0.032). The PCNA labelling index, c-erbB-2, CgA and p53 were not correlated to extent of invasion, lymph node metastasis, stage, or histologic type. CgA and c-erbB-2 expression and the PCNA labelling index thus had no prognostic value. With regard to p53, the 5-YSR of p53 negative cases was 68.6%; that of p53 positive cases was 47%, with significant difference (p=0.038).
This result suggests that p53 expression is related to poor prognosis of ampullary carcinoma, and that c-erbB-2 and CgA expression, and the PCNA labelling index, are not significant prognostic factors.


Ampullary carcinoma; p53 protein; Chromogranin A; c-erbB-2 gene; Proliferating cell nuclear antigen

MeSH Terms

Chromogranin A*
Genes, erbB-2
Lymph Nodes
Neoplasm Metastasis
Proliferating Cell Nuclear Antigen*
Retrospective Studies
Survival Rate
Chromogranin A
Proliferating Cell Nuclear Antigen
Full Text Links
  • JKCA
export Copy
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error